References
- Norgaard JM, Hokland P. Biology of multiple drug resistance in acute leukemia. In! J Hemato 2000; 72: 290–297.
- Linton KJ. Structure and function of ABC transporters. Physiology 2007; 22: 122–130.
- Testa U, Riccioni R. Deregulation of apoptosis in acute myeloidleukemia. Haematologica 2007; 92: 81–94.
- Danial NN. BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clin Cancer Res 2007; 13: 7254–7263.
- Schimmer AD. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res 2004; 64: 7183–7190.
- Jaffe ES, Harris NL, Stein H, Vardiman JW. eds. Pathology, and genetics of tumours of haematopoietic and lymphoid tissues (World Health Organization classification of tumours). Lyon: IARC Press, 2001.
- van Dongen JJ, Macintyre EA, Gabert JA et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 1901–1928.
- Veelken H, Licht T, Lais A et al. Drug resistance of secondary acute myeloid leukemia with megakaryoblastic features and p190 BCR-ABL rearrangement. Leuk Res 1998; 22: 1021–1027.
- Ryan B, O'Donovan N, Browne B et al. Expression of survivin andits splice variants survivin-2B and survivin-DEx3 in breast cancer. Br J Cancer 2005; 92: 120–124.
- Duffy MJ, O'Donovan N, Brennan DJ, Gallagher WM, Ryan BM. Survivin: a promising tumor biomarker. Cancer Lett 2007; 249:49–60.
- Badran A, Yoshida A, Wano Y et al. Expression of the anti-apoptotic gene survivin in myelodysplastic syndrome. Int J Oncol 2003; 22: 59–64.
- Adida C, Recher C, Raffoux E et al. Expression and prognostic significance of survivin in de novo acute myeloid leukaemia. Br J Haematol 2000; 111: 196–203.
- Li F. Survivin study: what is the next wave? J Cell Physiol 2003; 197: 8–29.
- Schimmer AD. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res 2004; 64: 7183–7190.
- Shin S, Sung BJ, Cho YS et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 2001; 40: 1117–1123.
- Banks DP, Plescia J, Altieri DC et al. Survivin does not inhibit caspase-3 activity. Blood 2000; 96: 4002–4003.
- Marusawa H, Matsuzawa S, Welsh K et al. HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J 2003; 22: 2729–2740.
- Alexandre S, Rast C, Nguyen-Ba G, Poirier GG, Vasseur P. PARP degradation in apoptotic Syrian hamster embryo (SHE) cells compared to HL60 cell line. Biochimie 2000; 82: 1115–1122.
- Germain M, Affar EB, D'Amours D, Dixit VM, Salvesen GS, Poirier GG. Cleavage of automodified poly(ADP-ribose) poly-merase during apoptosis. Evidence for involvement of caspase-7. J Biol Chem 1999; 274: 28379–28384.
- Duriez Pi, Shah GM. Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem Cell Biol 1997; 75: 337–349.
- Danial NN. BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clin Cancer Res 2007; 13: 7254–7263.
- Testa U, Riccioni R. Deregulation of apoptosis in acute myeloid leukemia. Haematologica 2007; 92: 81–94.
- Tamm I, Richter S, Scholz F et al. XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis. Hematol J 2004; 5: 489–495.
- Invernizzi R, Travaglino E, Lunghi M et al. Survivin expression in acute leukemias and myelodysplastic syndromes. Leuk Lymphoma 2004; 45: 2229–2237.
- Viatour P, Bentires-Alj M, Chariot A et al. NF-kappa B2/p100 induces Bc1-2 expression. Leukemia 2003; 17: 1349–1356.
- Hofer-Warbinek R, Schmid JA, Stehlik C, Binder BR, Lipp J, de Martin R. Activation of NF-kappa B by XIAP, the X chromo-some-linked inhibitor of apoptosis, in endothelial cells involves TAK1. J Biol Chem 2000.275: 22064–22068.
- Liu F, Xie ZH, Cai GP, Jiang YY. The effect of survivin on multidrug resistance mediated by P-glycoprotein in MCF-7 and its adriamycin resistant cells. Biol Pharm Bull 2007; 30: 2279–2283.
- Misra S, Ghatak S, Toole BP. Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2. J Biol Chem 2005; 280: 20310–20315.
- Xing H, Weng D, Chen G et al. Activation of fibronectin/PI-3K/ Akt2 leads to chemoresistance to docetaxel by regulating survivin protein expression in ovarian and breast cancer cells. Cancer Lett 2008; 261: 108–119.